Coastal Bridge Advisors’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$937K Sell
14,500
-156
-1% -$11K 0.07% 227
2025
Q4
$986K Buy
+14,656
New +$986K 0.07% 212
2025
Q3
Sell
-4,736
Closed -$246K 472
2025
Q2
$246K Buy
+4,736
New +$269K 0.02% 387
2024
Q2
Sell
-10,000
Closed -$407K 177
2024
Q1
$407K Buy
10,000
+2,000
+25% +$75K 0.09% 103
2023
Q4
$296K Buy
8,000
+2,000
+33% +$75.3K 0.08% 118
2023
Q3
$229K Hold
6,000
0.06% 130
2023
Q2
$216K Buy
+6,000
New +$205K 0.05% 135
2018
Q2
Sell
-60,153
Closed -$1.18M 133
2018
Q1
$1.18M Hold
60,153
0.43% 32
2017
Q4
$1.22M Hold
60,153
0.39% 30
2017
Q3
$1.04M Sell
60,153
-200
-0.3% -$2.71K 0.34% 36
2017
Q2
$774K Sell
60,353
-95,604
-61% -$1.28M 0.26% 45
2017
Q1
$2.02M Buy
+155,957
New +$1.97M 0.69% 18

Other funds holding HALO

Coastal Bridge Advisors's HALO Position: Q1 2026 in Review

Coastal Bridge Advisors reduced its Halozyme (HALO) stake by 1.1% in Q1 2026, selling an estimated $11K and leaving 14,500 shares worth $937K. The position accounts for 0.07% of the portfolio, ranked #227.

Coastal Bridge Advisors first reported a position in HALO in Q1 2017 and has held it in 12 quarters since. The position peaked at $2.02M in Q1 2017. 635 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

  • Coastal Bridge Advisors held 14,500 shares of Halozyme worth $937K as of Q1 2026.
  • Coastal Bridge Advisors sold 156 Halozyme shares in Q1 2026, an estimated $11K.
  • Halozyme made up 0.07% of Coastal Bridge Advisors's portfolio in Q1 2026, its #227 holding.
  • Coastal Bridge Advisors first reported a position in Halozyme in Q1 2017 and has held it in 12 quarters since.
  • Coastal Bridge Advisors's Halozyme position peaked at $2.02M in Q1 2017.
  • 635 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on Coastal Bridge Advisors's 13F filing for Q1 2026, filed 14 May 2026.